Failed Tablet/Capsule Specifications: Complaints received of crushed and broken tablets.
Classification
Class II
Status
Ongoing
Lot
Lot# NB240873, Exp 03/31/2026
Date
Disclaimer: This tool indexes published US FDA drug-enforcement recall records from all countries, limited to the latest five years. A company or product not appearing here is not proof that it is compliant, approved, safe, or free of FDA action.
Cipla USA, Inc. — Class II Recall | MedicineWatch US